Increased Peak postoperative b-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery

Anesthesiology

Volumn 114, Issue 4, 2011, Pages 807-816

  Fox, Amanda A ^d   Marcantonio, Edward R ^a   Collard, Charles D ^b   Thoma, Mathis ^c   Perry, Tjorvi E ^a   Shernan, Stanton K ^d   Muehlschlegel, Jochen D ^a   Body, Simon C ^d  

^a Beth Israel Deaconess Medical Center   (Israel)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATRIURETIC PEPTIDE RECEPTOR B;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL CAPACITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SHORT FORM 36;

EID: 79953229605     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31820ef9c1     Document Type: Article

References (40)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010; 121:e46-215
2. Loop FD, Lytle BW, Cosgrove DM, Goormastic M, Taylor PC, Golding LA, Stewart RW, Gill CC: Coronary artery bypass graft surgery in the elderly: Indications and outcome. Cleve Clin J Med 1988; 55:23-34 (Pubitemid 18057028)
3. Villareal RP, Lee VV, Elayda MA, Wilson JM: Coronary artery bypass surgery versus coronary stenting: Risk-adjusted survival rates in 5,619 patients. Tex Heart Inst J 2002; 29:3-9 (Pubitemid 34415215)
4. Rumsfeld JS, Magid DJ, O'Brien M, McCarthy M Jr, MaWhinney S, Shroyer AL, Moritz TE, Henderson WG, Sethi GK, Grover FL, Hammermeister KE; for the participants of the Department of Veterans Affairs Cooperative Study in Health Services: Processes, Structures, and Outcomes of Care in Cardiac Surgery: Changes in health-related quality of life following coronary artery bypass graft surgery. Ann Thorac Surg 2001; 72:2026-32 (Pubitemid 34001461)
5. Hawkes AL, Mortensen OS: Up to one third of individual cardiac patients have a decline in quality of life post-intervention. Scand Cardiovasc J 2006; 40:214-8
6. Lindsay GM, Hanlon P, Smith LN, Wheatley DJ: Assessment of changes in general health status using the short-form 36 questionnaire 1 year following coronary artery bypass grafting. Eur J Cardiothorac Surg 2000; 18:557-64
7. Kapetanakis EI, Stamou SC, Petro KR, Hill PC, Boyce SW, Bafi AS, Corso PJ: Comparison of the quality of life after conventional versus off-pump coronary artery bypass surgery. J Card Surg 2008; 23:120-5 (Pubitemid 351316812)
8. Vaccarino V, Lin ZQ, Kasl SV, Mattera JA, Roumanis SA, Abramson JL, Krumholz HM: Gender differences in recovery after coronary artery bypass surgery. J Am Coll Cardiol 2003; 41:307-14 (Pubitemid 36092202)
9. Daniels LB, Maisel AS: Natriuretic peptides. J Am Coll Cardiol 2007; 50:2357-68 (Pubitemid 50011582)
10. Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M: High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000; 36:1587-93
11. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, Cannon CP, Braunwald E: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-21
12. Grabowski M, Filipiak KJ, Karpinski G, Wretowski D, Rdzanek A, Huczek Z, Horszczaruk GJ, Kochman J, Rudowski R, Opolski G: Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute STelevation myocardial infarction treated with primary angioplasty. Am Heart J 2004; 148:655-62 (Pubitemid 39349386)
13. Bassan R, Tura BR, Maisel AS: B-type natriuretic peptide: A strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department. Coron Artery Dis 2009; 20:143-9
14. Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, Hlavin P, Maisel AS: B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002; 39:131-8 (Pubitemid 34118942)
15. Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R; Rapid Emergency Department Heart Failure Outpatient Trial investigators: Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT): A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 2004; 44:1328-33 (Pubitemid 39208893)
16. Doust JA, Pietrzak E, Dobson A, Glasziou P: How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic review. BMJ 2005; 330:625
17. Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E: B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: An ENTIRETIMI-23 substudy. J Am Coll Cardiol 2004; 44:335-9 (Pubitemid 38950592)
18. Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, Cambien F, Tiret L, Münzel T, Blankenberg S: B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: Results from the AtheroGene study. J Am Coll Cardiol 2006; 47:552-8 (Pubitemid 43170843)
19. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM: Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355:1126-30 (Pubitemid 30172933)
20. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juillière Y: Plasma brain natriuretic peptideguided therapy to improve outcome in heart failure: The STARS-BNP Multicenter Study. J Am Coll Cardiol 2007; 49: 1733-9 (Pubitemid 46589928)
21. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP; TIME-CHF Investigators: BNP-guided vs symptom-guided heart failure therapy: The Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 2009; 301:383-92
22. Bhardwaj A, Rehman SU, Mohammed A, Baggish AL, Moore SA, Januzzi JL Jr: Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study. Am Heart J 2010; 159:532-8 e1
23. Berendes E, Schmidt C, Van Aken H, Hartlage MG, Rothenburger M, Wirtz S, Scheld HH, Brodner G, Walter M: A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg 2004; 98:11-9, table of contents (Pubitemid 38029833)
24. Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS: Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004; 43:1873-9 (Pubitemid 38622529)
25. Cuthbertson BH, Amiri AR, Croal BL, Rajagopalan S, Brittenden J, Hillis GS: Utility of B-type natriuretic peptide in predicting medium-term mortality in patients undergoing major non-cardiac surgery. Am J Cardiol 2007; 100:1310-3 (Pubitemid 47500160)
26. Provenchère S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, Iung B, Dehoux M, Philip I, Bénessiano J: Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006; 34:995-1000
27. Fox AA, Muehlschlegel JD, Body SC, Shernan SK, Liu KY, Perry TE, Aranki SF, Cook EF, Marcantonio ER, Collard CD: Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting. ANESTHESIOLOGY 2010; 112:842-51
28. Fellahi JL, Hanouz JL, Manach YL, Gue X, Monier E, Guillou L, Riou B: Simultaneous measurement of cardiac troponin I, B-type natriuretic peptide, and C-reactive protein for the prediction of long-term cardiac outcome after cardiac surgery. ANESTHESIOLOGY 2009; 111:250-7
29. Wahl HG, Graf S, Renz H, Fassbinder W: Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem 2004; 50:1071-4 (Pubitemid 38725801)
30. Das SR, Abdullah SM, Leonard D, Drazner MH, Khera A, McGuire DK, de Lemos JA: Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study). Am J Cardiol 2008; 102:1394-8
31. Ware JE Jr, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME: User's Manual for the SF-36v2 Health Survey, 2nd edition. Lincoln, QualityMetric Inc, 2008
32. Fox AA, Collard CD, Shernan SK, Seidman CE, Seidman JG, Liu KY, Muehlschlegel JD, Perry TE, Aranki SF, Lange C, Herman DS, Meitinger T, Lichtner P, Body SC: Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting. ANESTHESIOLOGY 2009; 110:738-47
33. Fitzmaurice GM, Laird NM, Ware JH: Applied Longitudinal Analysis. Hoboken, John Wiley & Sons Inc, 2004
34. Taylor JM, Cooper KL, Wei JT, Sarma AV, Raghunathan TE, Heeringa SG: Use of multiple imputation to correct for nonresponse bias in a survey of urologic symptoms among African-American men. Am J Epidemiol 2002; 156:774-82 (Pubitemid 35155184)
35. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM Jr, Lytle BW, Marlow RA, Nugent WC, Orszulak TA: ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004; 110:e340-437
36. Welke KF, Stevens JP, Schults WC, Nelson EC, Beggs VL, Nugent WC: Patient characteristics can predict improvement in functional health after elective coronary artery bypass grafting. Ann Thorac Surg 2003; 75:1849-55 (Pubitemid 36677227)
37. Phillips Bute B, Mathew J, Blumenthal JA, Welsh-Bohmer K, White WD, Mark D, Landolfo K, Newman MF: Female gender is associated with impaired quality of life 1 year after coronary artery bypass surgery. Psychosom Med 2003; 65:944-51 (Pubitemid 38057793)
38. Kurlansky PA, Traad EA, Galbut DL, Singer S, Zucker M, Ebra G: Coronary bypass surgery in women: A long-term comparative study of quality of life after bilateral internal mammary artery grafting in men and women. Ann Thorac Surg 2002; 74:1517-25 (Pubitemid 35222633)
39. Rumsfeld JS, Magid DJ, Plomondon ME, Sacks J, Henderson W, Hlatky M, Sethi G, Morrison DA: Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia. J Am Coll Cardiol 2003; 41:1732-8 (Pubitemid 36584244)
40. Pasquali SK, Alexander KP, Coombs LP, Lytle BL, Peterson ED: Effect of cardiac rehabilitation on functional outcomes after coronary revascularization. Am Heart J 2003; 145: 445-51 (Pubitemid 36390490)